IRIS
D'ORONZO, STELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.570
EU - Europa 828
AS - Asia 669
SA - Sud America 193
AF - Africa 10
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.543
SE - Svezia 216
SG - Singapore 192
CN - Cina 189
BR - Brasile 175
RU - Federazione Russa 168
HK - Hong Kong 144
IT - Italia 97
DE - Germania 90
VN - Vietnam 70
GB - Regno Unito 68
FR - Francia 50
FI - Finlandia 37
ID - Indonesia 27
BE - Belgio 22
AT - Austria 15
CA - Canada 14
NL - Olanda 14
MX - Messico 9
IN - India 8
IL - Israele 7
UA - Ucraina 7
CZ - Repubblica Ceca 6
IE - Irlanda 6
IQ - Iraq 6
PL - Polonia 6
AL - Albania 5
AR - Argentina 5
BD - Bangladesh 5
TR - Turchia 5
ZA - Sudafrica 5
EE - Estonia 4
SA - Arabia Saudita 4
CO - Colombia 3
DK - Danimarca 3
ES - Italia 3
HN - Honduras 3
PE - Perù 3
UZ - Uzbekistan 3
CH - Svizzera 2
HU - Ungheria 2
IR - Iran 2
JP - Giappone 2
KE - Kenya 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
EC - Ecuador 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
MA - Marocco 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
UY - Uruguay 1
Totale 4.273
Salva come PNG Salva come JPEG
Città #
Fairfield 347
Chandler 312
Ashburn 183
Nyköping 176
Houston 158
Woodbridge 158
Seattle 153
Singapore 142
Hong Kong 140
Cambridge 135
Wilmington 120
Ann Arbor 94
Dong Ket 60
Beijing 54
Lawrence 48
Roxbury 45
New York 43
Nanjing 35
Munich 34
Jacksonville 28
Des Moines 27
Jakarta 27
Los Angeles 27
North Bergen 26
Helsinki 25
Brooklyn 24
Inglewood 23
Brussels 22
Paris 20
Bari 19
San Diego 18
The Dalles 18
Columbus 15
Dearborn 14
Santa Clara 14
London 13
Nuremberg 13
Council Bluffs 12
Princeton 12
Falls Church 11
São Paulo 11
Boardman 10
Guangzhou 9
Redwood City 9
Lauterbourg 8
Rio de Janeiro 8
Shenyang 8
Jiaxing 7
Moscow 7
Tianjin 7
Vienna 7
Amsterdam 6
Chicago 6
Dublin 6
Nanchang 6
St Albans 6
Tel Aviv 6
Washington 6
Brno 5
Dallas 5
Falkenstein 5
Frankfurt am Main 5
Hanoi 5
Islington 5
Jinan 5
Milan 5
Ottawa 5
Pune 5
Rome 5
Belo Horizonte 4
Changsha 4
Düsseldorf 4
Edinburgh 4
Toronto 4
West Jordan 4
Xian 4
Ankara 3
Baghdad 3
Buffalo 3
Campinas 3
Contagem 3
Guarulhos 3
Ho Chi Minh City 3
Mexico City 3
Phoenix 3
Ribeirão Preto 3
San Francisco 3
San Jose 3
Tallinn 3
Tashkent 3
Turku 3
Wenzhou 3
Wroclaw 3
Acton 2
Atlanta 2
Auckland 2
Brasília 2
Brighton 2
Cancellara 2
Candela 2
Totale 3.126
Salva come PNG Salva come JPEG
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 247
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 134
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 125
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 122
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 122
10-year patterns of recurrence from early breast cancer: Analyses of the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 120
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 118
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 118
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 115
Bone-sialoprotein (BSP), Dickkopf-1 (DKK1) and CXCR4 as potential biomarkers of breast cancer metastasis to bone: Analysis within the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 110
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 109
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 108
Ddx4+ Oogonial Stem Cells in Postmenopausal Women's Ovaries: A Controversial, Undefined Role 105
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 98
Perspective in infertility: the ovarian stem cells 98
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 98
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 98
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 96
Cancer Treatment and Bone Health 95
The role of biomarkers in the management of bone-homing malignancies 95
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 94
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 94
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 92
null 91
Breast cancer: an update on treatment-related infertility 91
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 91
Ovarian cancer: Novel molecular aspects for clinical assessment 86
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 82
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 79
Bone Metastases; Clinical Aspects 77
The value of biomarkers in bone metastasis 76
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management 76
In vitro generation of oocytes from ovarian stem cells (OSCs): In search of major evidence 74
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art 66
Medical Prevention and Treatment of Bone Metastases. 65
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 65
Reply: Improved understanding of very small embryonic-like stem cells in adult mammalian ovary 61
null 61
Pulmonary enteric adenocarcinoma: An overview 60
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 59
Bone metastases in hepatocellular carcinoma: an emerging issue 59
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 59
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 57
[Cell-based strategies: novel perspectives for cancer therapy]. FT Terapie cellulari in oncologia: recenti acquisizioni e sviluppi futuri 51
Uterine carcinosarcoma: An overview 47
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 46
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 45
Fertility preservation techniques in cervical carcinoma 43
Liquid biopsy in cervical cancer: Hopes and pitfalls 43
[Bone health in the oncologic patient]. FT La "bone health" nel paziente oncologico 42
Assessment of bone turnover markers and DXA parameters to predict bone metastasis progression during zoledronate treatment: a single-center experience 32
null 32
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 26
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations 25
null 23
The use of bisphosphonates to treat skeletal complications in solid tumours 23
Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view 21
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences 20
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update 19
Fertility Preservation in the Era of Immuno-Oncology: Lights and Shadows 18
Therapeutic approaches to myeloma bone disease: An evolving story 12
Vaccination of people with solid tumors and diabetes: existing evidence and recommendations. A position statement from a multidisciplinary panel of scientific societies 9
Totale 4.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.111
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021807 29 43 50 161 127 69 41 48 36 59 42 102
2021/2022458 24 8 15 13 17 50 13 23 45 54 62 134
2022/2023772 103 122 66 55 74 94 22 79 111 4 26 16
2023/2024336 18 66 22 43 26 86 4 14 7 11 10 29
2024/20251.173 34 17 103 62 36 107 130 111 74 73 160 266
2025/2026127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 4.623